BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17277112)

  • 1. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.
    Bochtler P; Kröger A; Schirmbeck R; Reimann J
    J Immunol; 2008 Aug; 181(3):1633-43. PubMed ID: 18641299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naïve CD8+ T cells in the mouse.
    Dikopoulos N; Wegenka U; Kröger A; Hauser H; Schirmbeck R; Reimann J
    Hepatology; 2004 May; 39(5):1256-66. PubMed ID: 15122754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.
    Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
    Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells.
    Dikopoulos N; Bertoletti A; Kröger A; Hauser H; Schirmbeck R; Reimann J
    J Immunol; 2005 Jan; 174(1):99-109. PubMed ID: 15611232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
    Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
    J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
    Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
    Fujii S; Shimizu K; Smith C; Bonifaz L; Steinman RM
    J Exp Med; 2003 Jul; 198(2):267-79. PubMed ID: 12874260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
    Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
    J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.